The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 17:357-363, August 2005
doi: 10.1176/appi.neuropsych.17.3.357
© 2005 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Staffen, W.
* Articles by Ladurner, G.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Staffen, W.
* Articles by Ladurner, G.
Related Collections
* Other Neuropsychiatric Disorders
* MRI

Magnetic Resonance Spectroscopy of Memory and Frontal Brain Region in Early Multiple Sclerosis

Wolfgang Staffen, M.D., Harald Zauner, Ph.D., Aldis Mair, M.D., Andrea Kutzelnigg, M.D., Peter Kapeller, M.D., Hilde Stangl, M.D., Edith Raffer, M.D., Helmut Niederhofer, M.D. and Gunther Ladurner, M.D.

Received June 9, 2003; revised June 15, 2004; accepted August 30, 2004. From the Christian-Doppler-Klinik, Department of Neurology, Salzburg, Austria; the Rehabilitation Center of the PVAng, Grossgmain, Austria; and the Karl-Franzens-Universität Graz, Austria. Address correspondence to Dr. Staffen, Neurological Department, Christian Doppler Klinik, Ignaz Harrer Strasse 79, 5020 Salzburg, Austria; w.staffen{at}salk.at (E-mail).

In vivo proton magnetic resonance spectroscopy (1H-MRS) has been used to assess biochemical changes that occur in demyelinating lesions and in normal appearing white matter (NAWM) in multiple sclerosis (MS) patients. N-acetylaspartate (NAA) levels in MS patients may indicate neural viability. In early stages of MS, patients may suffer from slight cognitive impairment. The objective of this study was to investigate memory function in relation to biochemical properties of frontal brain areas of MS patients. Twenty-one patients with relapsing-remitting MS and 21 healthy comparison subjects were examined psychometrically using the Wechsler Memory Scale (WMS) and the Multiple Sclerosis Functional Composite (MSFC) scale, and (1H-MRS) was used to examine frontal deep white matter (left hemisphere) and the frontal cingulate gyrus (Brodmann areas 24/32, bihemispheric). A significant reduction of the NAA/Creatine (Cr) ratio in the frontal cingulate gyrus among the MS patient group was detected when compared to healthy subjects. A significant decrease in the NAA/Cr ratio was also found in volumes of cerebral deep white matter, including plaques, in the MS patients. No NAA/Cr ratio changes were found in NAWM. Differences in MSFC results did not reach statistical significance, but the WMS general memory score showed a significant statistical difference between the patient group and healthy subjects. Regression analysis showed the gray matter NAA/Cr ratio of the frontal cingulate gyrus to be significantly related to distinct memory functions. The authors conclude that (1H-MRS) of gray matter in early stages of MS may be pertinent in the detections of early metabolic disturbances, particularly in subjects with or without minor neurological impairment. Findings suggest a general relationship between the metabolic status of the frontal cortices and memory function.

Key Words: Magnetic Resonance Spectroscopy • Cingulate gyrus • Memory • Multiple Sclerosis







Get information about faster international access.

Privacy Policy

Copyright © 2005 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org